🦟 Chikungunya: Managing the Fever and the Long‑Lasting Joint Pain

Chikungunya is a viral illness that shares its mosquito vector with dengue, and its initial symptoms — sudden high fever and severe body pain — can be mistaken for it. What sets chikungunya apart is the excruciating and often prolonged joint pain that can persist for months or even years after the fever subsides, significantly affecting quality of life. Dr. Ravi Sishir Reddy explains what chikungunya is, how the acute illness is managed, and the strategies to cope with the lingering arthritis.

1. What Is Chikungunya?

Chikungunya is caused by the chikungunya virus (CHIKV), an alphavirus transmitted to humans by the same Aedes aegypti and Aedes albopictus mosquitoes that spread dengue. The name comes from a Makonde word meaning "to become contorted" or "that which bends up" — a graphic description of the stooped posture caused by intense joint pain. Unlike dengue, which can cause life‑threatening haemorrhage and shock, chikungunya is very rarely fatal. However, its hallmark persistent arthritic pain can be debilitating. The virus was historically confined to Africa and Asia but has spread globally, causing major outbreaks in India, particularly in the post‑monsoon period.

2. The Acute Phase: High Fever and Intense Pain

Symptoms appear abruptly 3‑7 days after a mosquito bite. The acute illness typically lasts 7‑10 days and includes:

• Sudden high fever — often above 102°F (39°C), accompanied by chills.
• Severe polyarthralgia (multiple joint pain): The defining feature. The pain is often symmetrical, affecting the wrists, fingers, ankles, knees, and elbows. It can be so severe that the patient cannot hold a cup, walk, or perform basic tasks. Joints may also be swollen and tender.
• Intense muscle pain and backache.
• Headache and fatigue.
• A maculopapular rash appears in about 50% of patients, usually on the trunk and limbs, starting 2‑5 days after the fever. It may be itchy.
• Some patients experience nausea, vomiting, and conjunctivitis.

During the acute phase, it can be difficult to distinguish chikungunya from dengue. A key difference is that while dengue causes a drop in platelet count, chikungunya typically does not — platelet levels usually remain normal or are only mildly reduced. This is one reason why laboratory testing is important.

3. How Is Chikungunya Diagnosed?

Dr. Reddy advises that laboratory confirmation is important, especially during outbreaks when dengue is also circulating. The main diagnostic tests are:

• RT‑PCR (Reverse Transcription‑Polymerase Chain Reaction): Detects the virus's genetic material in the blood. It is most useful during the first 5‑7 days of illness when the virus is still present in the blood.
• Serology (IgM and IgG antibodies): IgM antibodies against CHIKV appear around day 5‑7 and peak at 3‑5 weeks. A positive IgM test confirms recent infection. IgG antibodies appear later and indicate past infection or immunity.

A complete blood count (CBC) is often done to differentiate from dengue — a normal or mildly low platelet count supports chikungunya over dengue, but co‑infection with both viruses can occur.

4. Managing the Acute Phase: Rest, Hydration, and Pain Relief

There is no specific antiviral treatment for chikungunya. Management is entirely supportive, focusing on controlling symptoms until the body clears the virus:

• Hydration: Drink plenty of water, ORS, coconut water, and clear soups to prevent dehydration from fever.
• Rest: Complete physical rest during the febrile phase is crucial. Movement can aggravate joint inflammation.
• Pain relief:
  • Paracetamol (acetaminophen) is the first‑line medication for fever and mild to moderate pain.
  • NSAIDs (ibuprofen, naproxen, diclofenac) are effective for more severe joint pain and inflammation because they have anti‑inflammatory properties. However, they must be avoided until dengue has been definitively ruled out, as NSAIDs can cause dangerous bleeding in dengue. If dengue is excluded, a short course of NSAIDs under medical guidance can be very helpful during the acute phase.
  • Avoid aspirin for the same reason — bleeding risk.
• Gentle movement: While rest is important, complete immobilisation can worsen stiffness. Gentle range‑of‑motion exercises — slowly moving the wrists, fingers, ankles, and knees through their full range without force — can help prevent stiffness. A physiotherapist can provide guidance.

5. The Chronic Phase: When Joint Pain Persists for Months

This is the most challenging aspect of chikungunya. Up to 40‑60% of patients experience persistent or recurrent joint pain that can last for months to years after the initial infection. The pain is typically inflammatory in nature — worse in the morning, with stiffness that improves with movement, and swelling that comes and goes. The hands, wrists, and ankles are most commonly affected. This chronic phase can mimic rheumatoid arthritis, and in some patients, it can be disabling.

Dr. Reddy explains the current understanding: the virus itself may be cleared from the blood within a week, but viral RNA can persist in joint tissues, triggering an ongoing inflammatory response. The immune system, primed to attack the virus, may also continue to attack the joint lining, causing chronic synovitis. Risk factors for prolonged joint pain include older age (over 45), pre‑existing osteoarthritis, and a more severe acute illness.

6. Managing Chronic Chikungunya Arthritis

For persistent joint pain, a multimodal approach — combining medication, physiotherapy, and lifestyle adjustments — is most effective:

• NSAIDs: A prolonged course of NSAIDs under medical supervision can control pain and inflammation. The doctor will prescribe the lowest effective dose for the shortest necessary duration and monitor for stomach, kidney, and cardiovascular side effects. Taking them with food is essential.
• Disease‑modifying antirheumatic drugs (DMARDs): If symptoms persist for more than 3‑6 months and resemble rheumatoid arthritis, drugs like hydroxychloroquine (an immunomodulator) or methotrexate may be prescribed by a rheumatologist. These drugs dampen the overactive immune response in the joints. They take weeks to months to work and require regular blood tests to monitor for side effects.
• Corticosteroids: A short course of low‑dose prednisolone can quickly reduce severe inflammation and provide relief, but it must be used with caution and never as a long‑term solution due to side effects (weight gain, osteoporosis, diabetes, and immunosuppression).
• Physiotherapy and gentle exercise: A physiotherapist can design a programme of low‑impact exercises — such as stretching, yoga, swimming, and stationary cycling — that strengthen the muscles around the joints without worsening pain. This is critical for maintaining mobility and preventing contractures. Applying warm compresses to stiff joints in the morning and ice packs after activity can help.
• Topical analgesics: Gels containing diclofenac or capsaicin can provide localised relief with fewer systemic side effects.

Dr. Reddy emphasises that patients should be reassured — the pain is real, it is not "in their head," and while recovery can be slow, the vast majority of people do eventually improve significantly over time. Aggressive pain management in the early months can prevent chronic pain syndromes from becoming entrenched.

7. Prevention: The Same Mosquito‑Avoidance Strategies

Preventing chikungunya relies entirely on avoiding mosquito bites and eliminating breeding sites — the same measures described for dengue. There is currently no licensed vaccine for chikungunya, though several candidates are in development. Until a vaccine becomes available, community‑level mosquito control and personal protection (repellents, nets, protective clothing) remain the only defences.